JP2022518929A5 - - Google Patents
Info
- Publication number
- JP2022518929A5 JP2022518929A5 JP2021544144A JP2021544144A JP2022518929A5 JP 2022518929 A5 JP2022518929 A5 JP 2022518929A5 JP 2021544144 A JP2021544144 A JP 2021544144A JP 2021544144 A JP2021544144 A JP 2021544144A JP 2022518929 A5 JP2022518929 A5 JP 2022518929A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- sequence
- modified
- acid bases
- equal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024158813A JP2025000693A (ja) | 2019-01-29 | 2024-09-13 | Appの発現を低減するための化合物及び方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798353P | 2019-01-29 | 2019-01-29 | |
| US62/798,353 | 2019-01-29 | ||
| US201962841169P | 2019-04-30 | 2019-04-30 | |
| US62/841,169 | 2019-04-30 | ||
| US201962915764P | 2019-10-16 | 2019-10-16 | |
| US62/915,764 | 2019-10-16 | ||
| PCT/US2020/015701 WO2020160163A1 (en) | 2019-01-29 | 2020-01-29 | Compounds and methods for reducing app expression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024158813A Division JP2025000693A (ja) | 2019-01-29 | 2024-09-13 | Appの発現を低減するための化合物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022518929A JP2022518929A (ja) | 2022-03-17 |
| JP2022518929A5 true JP2022518929A5 (cg-RX-API-DMAC7.html) | 2023-02-02 |
| JP7557469B2 JP7557469B2 (ja) | 2024-09-27 |
Family
ID=71840111
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544144A Active JP7557469B2 (ja) | 2019-01-29 | 2020-01-29 | Appの発現を低減するための化合物及び方法 |
| JP2024158813A Pending JP2025000693A (ja) | 2019-01-29 | 2024-09-13 | Appの発現を低減するための化合物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024158813A Pending JP2025000693A (ja) | 2019-01-29 | 2024-09-13 | Appの発現を低減するための化合物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220380773A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3918073A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7557469B2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202043472A (cg-RX-API-DMAC7.html) |
| UY (1) | UY38562A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020160163A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY203356A (en) | 2018-01-12 | 2024-06-25 | Bristol Myers Squibb Co | Antisense oligonucleotides targeting alpha-synuclein and uses thereof |
| WO2019140236A1 (en) | 2018-01-12 | 2019-07-18 | Bristol-Myers Squibb Company | Antisense oligonucleotides targeting alpha-synuclein and uses thereof |
| WO2019169243A1 (en) | 2018-03-02 | 2019-09-06 | Ionis Pharmaceuticals, Inc. | Compounds and methods for the modulation of amyloid-beta precursor protein |
| AU2019405783B2 (en) * | 2018-12-19 | 2026-03-26 | Alnylam Pharmaceuticals, Inc. | Amyloid precursor protein (APP) RNAi agent compositions and methods of use thereof |
| JP7725370B2 (ja) * | 2019-04-03 | 2025-08-19 | ブリストル-マイヤーズ スクイブ カンパニー | Angptl2アンチセンスオリゴヌクレオチドおよびその使用 |
| KR20220062517A (ko) | 2019-08-15 | 2022-05-17 | 아이오니스 파마수티컬즈, 인코포레이티드 | 결합 변형된 올리고머 화합물 및 이의 용도 |
| MX2023001222A (es) | 2020-07-28 | 2023-04-26 | Ionis Pharmaceuticals Inc | Compuestos y metodos para reducir la expresion de app. |
| WO2022165172A1 (en) * | 2021-01-29 | 2022-08-04 | Alnylam Pharmaceuticals, Inc. | Irna compositions and methods for silencing amyloid precursor protein (app) |
| EP4416284A1 (en) * | 2021-10-15 | 2024-08-21 | Alnylam Pharmaceuticals, Inc. | Extra-hepatic delivery irna compositions and methods of use thereof |
| WO2025045195A1 (zh) * | 2023-08-31 | 2025-03-06 | 上海拓界生物医药科技有限公司 | 靶向APP的RNAi剂及其医药用途 |
| WO2025228429A1 (zh) * | 2024-04-30 | 2025-11-06 | 北京安龙生物医药有限公司 | 靶向淀粉样前体蛋白基因的寡核苷酸及其用途 |
| WO2025261396A1 (zh) * | 2024-06-18 | 2025-12-26 | 艾码生物科技(南京)有限公司 | 靶向app的rna干扰方法、核酸及其应用 |
| WO2026092658A2 (en) * | 2024-10-31 | 2026-05-07 | Sanegene Bio Usa Inc. | Small interfering rna targeting amyloid beta precursor protein (app) and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06511387A (ja) * | 1991-12-24 | 1994-12-22 | アイシス・ファーマシューティカルス・インコーポレーテッド | β−アミロイド調節のための組成物および方法 |
| US20030232435A1 (en) * | 2002-06-14 | 2003-12-18 | Isis Pharmaceuticals Inc. | Antisense modulation of amyloid beta protein precursor expression |
| CA2528963A1 (en) * | 2003-06-27 | 2005-01-13 | Sirna Therapeutics, Inc. | Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina) |
| GB0324854D0 (en) * | 2003-10-24 | 2003-11-26 | Expresson Biosystems Ltd | App/ena antisense |
| US20110166197A1 (en) | 2008-02-19 | 2011-07-07 | Edunn Biotechnology, Inc. | Antisense Modulation Of Amyloid Beta Protein Expression |
| US20100190807A1 (en) * | 2008-08-26 | 2010-07-29 | Senex Biotechnology, Inc. | CDKI Pathway inhibitors and uses thereof to regulate expression to TAU protein |
| WO2011130742A2 (en) * | 2010-04-16 | 2011-10-20 | Wisconsin Alumni Research Foundation | Diagnostic evaluation of antibody responses to commonly recognized prostate cancer-associated antigens |
| KR20160027968A (ko) | 2013-06-07 | 2016-03-10 | 라나 테라퓨틱스, 인크. | Foxp3 발현을 조절하기 위한 조성물 및 방법 |
| JP2016531570A (ja) | 2013-08-16 | 2016-10-13 | ラナ セラピューティクス インコーポレイテッド | ユークロマチン領域を標的とするオリゴヌクレオチド |
| MY192689A (en) | 2013-10-11 | 2022-09-01 | Ionis Pharmaceuticals Inc | Compositions for modulating c9orf72 expression |
| US9926556B2 (en) | 2014-04-28 | 2018-03-27 | Ionis Pharmaceuticals, Inc. | Linkage modified oligomeric compounds |
| WO2019169243A1 (en) * | 2018-03-02 | 2019-09-06 | Ionis Pharmaceuticals, Inc. | Compounds and methods for the modulation of amyloid-beta precursor protein |
-
2020
- 2020-01-29 JP JP2021544144A patent/JP7557469B2/ja active Active
- 2020-01-29 WO PCT/US2020/015701 patent/WO2020160163A1/en not_active Ceased
- 2020-01-29 US US17/424,672 patent/US20220380773A1/en active Pending
- 2020-01-29 EP EP20749114.3A patent/EP3918073A4/en active Pending
- 2020-01-29 UY UY0001038562A patent/UY38562A/es not_active Application Discontinuation
- 2020-01-30 TW TW109102899A patent/TW202043472A/zh unknown
-
2024
- 2024-09-13 JP JP2024158813A patent/JP2025000693A/ja active Pending